Abstract
Our aim was to investigate plasma levels of adiponectin, monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in low birth weight (LBW) children and to determine correlations among these adipokines and birth weight and cardiovascular disease risk factors. In a case–control study, the concentrations of adiponectin, MCP-1 and PAI-1 were measured in 180 schoolchildren (ages 6–11 years). MCP-1 and PAI-1 levels were significantly elevated in LBW children. Conversely, adiponectin concentration was significantly reduced in these children. Similar findings were observed after adjustment for current age, gender and abdominal circumference. Because the children with LBW had altered adipokine levels, as well as higher abdominal circumference, HOMA-IR and systolic blood pressure (SBP), we evaluated the correlation among these variables. These analyses showed that adiponectin levels were inversely correlated with systolic blood pressure (SBP) (r = −0.501; P < 0.001), HOMA-IR (r = −0.293; P = 0.023) and waist circumference (r = −0.317; P = 0.014). The proinflammatory markers were positively correlated with HOMA-IR (PAI-1: r = 0.358; P = 0.005) and waist circumference (PAI-1: r = 0.571; P < 0.001 and MCP-1: r = 0.267; P = 0.039). Conclusion: Adipokines levels were correlated with cardiovascular risk factors in LBW children, and these compounds could be involved in the mechanism that links birth weight to the development of cardiovascular diseases in adulthood.
Similar content being viewed by others
References
Alessi MC, Poggi M, Juhan-Vogue I (2007) Plasminogen activator inibitor-1 adipose tissue and insulin resistence. Curr Opin Lipidol 18(3):240–245
Barker DJ (1999) The fetal origins of type 2 diabetes type 2 mellitus. Ann Intern Med 130:322–324
Barker DJ, Bagby SP (2005) Developmental antecedents of cardiovascular disease: a historical perspective. J Am Soc Nephrol 16:2537–2544
Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PMS (1993) Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62–67
Berenson GS (2002) Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. the Bogalusa Heart Study. Am J Cardiol 90:3L–7L
Boutsikou T, Mastorakos G, Kyriakakou M et al (2010) Circulating levels of inflammatory markers in intrauterine growth restriction. Mediat Inflamm. doi:10.1155/2010/790605
Briana D, Malamitsi-Puchner A (2009) Intrauterine growth restriction and adult disease: the role of adipokines. Eur J Endocrinol 160:337–347
Bursztyn M, Ariel I (2006) Maternal-fetal deprivation and the cardiometabolic syndrome. J Cardiometab Syndr 1:141–145
Challa AS, Evangelidou EN, Cholevas VJ et al (2009) Growth factors and adipokines in prepubertal children born small for gestational age. Diabetes Care 32:714–719
Cianfarani S, Martinez C, Maiorana A et al (2004) Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catch-up growth. J Clin Endocrinol Metab 89:1346–1351
Cook JM, Semple RK (2010) Hypoadiponectinemia—cause or consequence of human “insulin resistance” ? J Clin Endocrinol Metab 95:1544–1554
De Las HJ, Bacha F, Tfayli H (2011) Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents. Horm Res Paediatr 76:379–385
Franco MC, Christofalo DM, Sawaya AL, Sesso R (2006) Effects of low birth weight in 8- to 13-year-old children: implications in endothelial function and uric acid levels. Hypertension 48:45–50
Franco MC, Higa EM, D’Almeida V, Sesso R (2007) Homocysteine and nitric oxide are related to blood pressure and vascular function in small-for-gestational-age children. Hypertension 50:396–402
Friedewald WT, Levy RI, Frederickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preoperative ultracentrifuge. Clin Chem 18:499–502
Fukami A, Sho-ichi Y, Hisashi A et al (2011) High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population. Clin Cardiol 34(3):189–194
Giordano P, Del Vecchio GC, Cecinati V et al (2011) Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr 170(7):845–850
Gluckman PD, Hanson MA, Buklijas T (2010) A conceptual framework for the developmental origins of health and disease. J Dev Orig Health Dis 1:6–18
Huxley R, Owen CG, Whincup PH et al (2007) Is birth weight a risk factor for ischemic heart disease in later life? Am J Clin Nutr 85(5):1244–1250
Ibanez L, Lopez-Bernejo A, Marcos MV et al (2008) Visceral adiposity without overweight in children born small for gestational age. J Clin Endocrinol Metab 93(6):2079–2083
Kamoda T, Saitoh H, Saito M et al (2004) Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res 56:690–693
Kaur S, Panicker SR, James T (2009) Association of monocyte chemoattractant protein-1-2518 polymorphism with metabolic syndrome in a South Indian cohort. Metab Syndr Relat Disord 7:193–198
Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556
Keskin M, Kurtoglu S, Kendirci M et al (2005) Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115(4):500–503
Körner A, Kratzsch J, Gausche R et al (2007) New predictors of the metabolic syndrome in children—role of adipocytokines. Pediatr Res 61:640–645
Labayen I, Ortega FB, Sjistrom M, Ruiz JR (2009) Early life origins of low-grade inflammation and atherosclerosis risk in children and adolescents. J Pediatr 155:673–677
Lambert M, O’Loughlin J, Delvin EE (2009) Association between insulin, leptin, adiponectin and blood pressure in youth. J Hypertens 27:1025–1032
Lau DC, Dhillon B, Yan H (2005) Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288:H2031–H2041
Leeson CPM, Kattenhorn M, Morley R (2001) Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 103:1264–1268
Levy-Marchal C, Jaquet D, Czernichow P (2004) Long-term metabolic consequences of being born small for gestational age. Semin Neonatol 9:67–74
López-Bernejo A, Casano-Sancho P (2007) Insulin resistance after precocious pubarche: relation to PAI-1-675 4G/5G polymorphism, and opposing influences of prenatal and postnatal weight gain. Clin Endocrinol (Oxf) 67:493–499
Maiorana A, Del Bianco C, Cianfarani S (2007) Adipose tissue: a metabolic regulator, potential implications for the metabolic outcome of subjects born small for gestacional age (SGA). Rev Diabet Stud 4:134–146
Martin H, Hu J, Gennser G (2000) Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birth weight. Circulation 102:2739–2744
Matheus DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Meas T, Deghmoun S, Chevenne D (2010) Plasminogen activator inhibitor type-1 is an independent marker of metabolic disorders in young adults born small for gestational age. J Thromb Haemost 12:2608–2613
Muhlhausler B, Smith SR (2008) Early-life origins of metabolic dysfunction: role of the adipocyte. Trends Endocrinol Metab 20(2):51–57
National High Blood Pressure Education priogram Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evalution, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576
Riestra P, García-Anguita A, Lasunción MA (2011) Relationship of adiponectin with metabolic syndrome components in pubertal children. Atherosclerosis 216:467–470
Sattar N, McConnachie A, O’Reilly D et al (2004) Inverse association between birth weight and C-reative protein concentrations in the MIDSPAN Family Study. Arterioscler Thromb Vasc Biol 24:583–587
Shatat IF, Freeman KD, Vuguin PM (2009) Relationship between adiponectin and ambulatory blood pressure in obese adolescents. Pediatr Res 65:691–695
Strufaldi MWL, Silva EMK, Puccini RF (2008) Metabolic syndrome among prepubertal Brazilian schoolchildren. Diab Vasc Dis Res 5(4):291–297
Winer JC, Zern TL, Taksali SE (2006) Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 91:4415–4423
Zhang H, Cui J, Zhang C (2010) Emerging role of adipokiness as mediators in atherosclerosis. World J Cardiol 2(11):370–376
Acknowledgment
This research has been supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo, Brazil). Project numbers 08/58963-0 (MWLS) and 07/58044-2 (MCPF).
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strufaldi, M.W.L., Puccini, R.F., Silvério, O.M.A. et al. Association of adipokines with cardiovascular risk factors in low birth weight children: a case–control study. Eur J Pediatr 172, 71–76 (2013). https://doi.org/10.1007/s00431-012-1846-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-012-1846-x